Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(17):1252-1253; doi:10.1093/jnci/djj336
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Thirumaran, R. K.
Right arrow Articles by Kumar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thirumaran, R. K.
Right arrow Articles by Kumar, R.
Related Collections
Right arrowRelated Article in JNCI
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

CORRESPONDENCE

Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk

Ranjit K. Thirumaran, Adina Thoelke, Selma Ugurel, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar

Affiliations of authors: Division of Molecular Genetic Epidemiology (RKT, AT, KH, RK), Skin Cancer Unit (AT, SU, DS), German Cancer Research Center, Heidelberg, Germany; Department of Biosciences and Nutrition, Karolinska Institute, Novum, Huddinge, Sweden (KH, RK)

Correspondence to: Rajiv Kumar, PhD, Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany (e-mail: r.kumar@dkfz.de).

The first 10% of the full text of this article appears below.

The known genetic risk factors for malignant melanoma, besides CDKN2A and CDK4 mutations, include variant alleles of the melanocortin-1 receptor (MC1R) gene (1). Recently, Soufir et al. (2) in a study that was based on 137 malignant melanoma patients and 131 ethnically matched control subjects reported an association between nonsynonymous variants in the endothelin receptor B (EDNRB) gene . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Nadem Soufir, Roubila Meziani, Jean-Jacques Lacapère, Guylene Bertrand, Frederic Fumeron, Agnes Bourillon, Bénédicte Gérard, Vincent Descamps, Béatrice Crickx, Laurence Ollivaud, Alain Archimbaud, Céleste Lebbe, Nicole Basset-Seguin, Philippe Saiag, and Bernard Grandchamp for the Investigators of the Melan-Cohort
J Natl Cancer Inst 2005 97: 1297-1301. [Abstract] [Full Text] [PDF]

Response to this Correspondence

RESPONSE: Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Nadem Soufir and Bernard Grandchamp
J Natl Cancer Inst 2006 98: 1253. [Extract] [Full Text] [PDF]